COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019 in Wuhan city, Hubei province, China. This is the third and largest coronavirus outbreak since the new millennium after SARS in 2002 and Middle East respiratory syndrome (MERS) in 2012. Over 3 million people ha...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Ophthalmol
Autors principals: Thng, Zheng Xian, De Smet, Marc D, Lee, Cecilia S, Gupta, Vishali, Smith, Justine R, McCluskey, Peter J, Thorne, Jennifer E, Kempen, John H, Zierhut, Manfred, Nguyen, Quan Dong, Pavesio, Carlos, Agrawal, Rupesh
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7316101/
https://ncbi.nlm.nih.gov/pubmed/32532764
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2020-316586
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars